Start here if you're new
what it is
Tredegar makes aluminum shapes and specialty plastic films that other manufacturers need to finish their own products.
how it gets paid
Last year Tredegar made $597M in revenue.
what just happened
The latest quarter delivered $0.55 EPS, but the longer record still shows a business with uneven earnings.
At a glance
B balance sheet — gets the job done, barely
10/100 earnings predictability — expect surprises
9.7x trailing p/e — the market's not buying it — or you found a deal
5.0% return on capital — nothing to write home about
$0.28 fy2024 eps est
xvary composite: 51/100 — below average
What they do
Tredegar makes aluminum shapes and specialty plastic films that other manufacturers need to finish their own products.
Tredegar wins by being buried inside dull but necessary supply chains. It serves building products, transportation, and packaging across 3 reportable segments, which spreads demand better than betting on one niche. You are not paying for glamour here. You are paying for a supplier with 1,500 employees that already sits where customers need product to show up on time.
How they make money
$597M
annual revenue
total revenue
$597M
n/a
The products that matter
manufactures custom metal parts
Custom Aluminum Extrusions
$387M · 53.5% of revenue
it's the larger segment at $387M, but growth was 12% — solid, not explosive. this is the steadier side of the business.
construction + auto exposed
makes specialty masking films
Tredegar Surface Protection
$336M · +33% growth
this $336M segment grew 33% last year. when one half of the company grows that much faster than the other, you pay attention.
growth engine
Key numbers
$597M
2024 sales est.
Plain English: this is the revenue base behind the stock. So what: against a roughly $271 million market cap, you are paying about 0.45 times sales.
9.7x
trailing p/e
P/E → price-to-earnings ratio → how many dollars investors pay for $1 of profit. So what: the stock is priced like the market does not trust the profit stream.
7.6%
operating margin
Operating margin → profit left after running the business → the cushion before interest and taxes. So what: this is positive, but not fat enough to absorb many mistakes.
5.0%
return on capital
Return on capital → profit earned on the money tied up in the business → how productive the assets are. So what: 5.0% is weak and explains why this stock stays cheap.
Financial health
B
strength
- balance sheet grade B — adequate — nothing special
- risk rank 3 — safer than 50% of stocks
- price stability 30 / 100
- long-term debt $61M (18% of capital)
B — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for TG right now.
source: institutional data · return history unavailable
What just happened
beat estimates
The latest quarter delivered $0.55 EPS, but the longer record still shows a business with uneven earnings.
The base data also shows fiscal 2024 EPS of $0.28 after a fiscal 2023 loss of $0.68. That is a recovery, not a clean trend.
revenue
$0.55
eps
gross margin
the number that mattered
$0.55 EPS matters because it shows Tredegar can still produce earnings power, but one quarter does not erase a full-year loss from 2023.
source: company filings / consensus data
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top risk is the durability of the 2025 turnaround under brand-new leadership.
high
fraud-related audit misstatement risk
on jun 20, 2024, the auditor flagged the risk of not detecting a material misstatement from fraud.
if controls are weaker than they look, the 2025 profit rebound loses credibility fast.
med
management reset risk
Arijit DasGupta became CEO and Paul Goldschmiedt became CFO effective jan 1, 2026.
a turnaround is hard enough. doing it with a brand-new CEO and CFO raises the execution bar.
med
growth concentration in one segment
Surface Protection grew 33% last year, versus 12% for Aluminum Extrusions.
if the faster-growing segment cools off, the whole rebound starts looking thinner than the headline revenue number suggests.
low
institutional ownership concentration
79.24% of the stock is institutionally owned, and Gabelli Funds had 5.8% of its assets in TG as of sep 2025.
when ownership is this concentrated in a $271M company, fund flows can move the stock more than fundamentals in the short run.
these risks sit on top of a business with a $271M market cap, 10/100 earnings predictability, and just $14.6M of full-year net income. there is not much cushion here.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
Surface Protection growth rate
it grew 33% last year. if that number normalizes hard, the recovery story loses its strongest proof point.
risk
audit and control disclosures
the prior fraud-related audit warning is the kind of thing you watch until it stops being relevant.
calendar
first full strategy update from the new CEO and CFO
leadership changed on jan 1, 2026. the first clear capital allocation and operating plan will matter more than ceremonial language.
trend
institutional ownership flow
79.24% institutional ownership can help on the way up and hurt on the way down. small-cap liquidity works both ways.
Analyst rankings
earnings predictability
10 / 100
in human-speak, analysts do not view TG's earnings stream as especially dependable.
risk rank
3
that puts it around the middle on safety. not a bunker stock, not the edge of a cliff.
source: institutional data
Institutional activity
institutional ownership data for TG is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$8
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive